First-line immune checkpoint inhibitor-based combinations in unresectable hepatocellular carcinoma: current management and future challenges

  • Alessandro Rizzo
    Department of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi University Hospital, Bologna, Italy
  • Angela Dalia Ricci
    Department of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi University Hospital, Bologna, Italy
  • Gennaro Gadaleta-Caldarola
    Department of Medical Oncology, Medical Oncology Unit, “Mons. R. Dimiccoli” Hospital, Barletta (BT), ASL BT, Italy
  • Giovanni Brandi
    Department of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi University Hospital, Bologna, Italy

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ